@niniandthebrain

@niniandthebrain has been a member of Linktree for 5 years and joined in March 2021. The social media accounts linked to from @niniandthebrain are: Instagram, Email. Besides social media accounts, niniandthebrain has populated their site with niniandthebrain.com, techingitapart.substack.com, destecando.substack.com, Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 - Nature Medicine, Live Zoom with Immunologist Azza Gadir and Catherine Wu from the Atlantic, Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients, Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening, Less Infectious Virus in Breakthroughs than Those not Vaccinated (HCW), Scale of Economic Downturn - Sweden and Other countries, Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic, CDC-1918 Spanish Flu Pandemic, Why some Flu's are Deadliest Amongst Young adults, Mass Vaccination won't lead to more virulent variants, Clinical Characteristics of Breakthrough Infections, VE Over time Israel (delta), How Delta replicates so quickly, Why iS C-19 less Severe in Kids?, Mixing Vaccines, UK VE over Time VS. Delta, Israel VE over time, MMWR VE for Nursing Home Residents, Mayo Clinic Study: Moderna vs. Pfizer VS Delta, mRNA VE Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021, VE against Infection/Hospitalization NY May-July during Delta, Full vaccination Suppresses Delta mutation frequency, ssociation of country-wide coronavirus mortality with demographics, testing, lockdowns, and public wearing of masks, Mask mandates led to a slowdown in daily COVID-19 growth rate, High-speed video evidence of coverings blocking droplets, Masks Against Covid-19: A Review, Masks Used for Influenza, Viral loads drop off faster in those vaccinated, Vaccine Effectiveness (Delta) Canada, Delta Effectiveness Study UK, Delta Effectiveness in Scotland, Covid-19 Vaccine Myths through logic, Neutralizing Antibodies highly predictive of Immune protection, Neutralizing Titers in Those Recovered vs. Vaccination, Exhaled aerosol risk markers with COVID-19 infection, IVM- Insufficient data for Safety or Efficacy, Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities, Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity, Genetic Epidemiology of Delta Strain, Lambda: Why no Need to Worry Right now, Variants emerge in Unvaccinated, References for History of mRNA, Vaccine Effectiveness (mRNA and AstraZeneca) Against Delta VOC, Temperature dependent virus host dynamics in upper airways, Misrepresentation and distortion of research in biomedical literature, Respiratory virus shedding in exhaled breath and efficacy of face masks, Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering, Re-infection Tracker, Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US, Re-infections in the UK from Delta, What comes next? -> Pandemic:: Has the Sprint Turned into a Marathon?, CDC Guidance for Reinfection Surveillance, Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses, Viral Reservoirs after Infection and Long Covid-19, Reinfections in Denmark, UK Reinfection Surveillance, Pfizer EMA briefing Document showing distribution of vaccine dose, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Understanding Spike Protein Circulation after vaccination, Circulating Spike protein post vaccination, The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD, Distinct SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination, Neutralizing vs. Binding Antibodies in Those Recovered from SARS-2 infection vs. Vaccination, No Association between mRNA and facial paralysis, Real World Data on Vaccine Side Effects, STOIC Oxford Study on Inhaled Budesonide, References for Economy vs. Lives, Vaccine Effectiveness Israel MoH, Novavax vs. B.1.351 Variant, Real World Effectiveness Canada PH Ontario, Safety and Efficacy of Janssen's Single Dose Vaccine, Pfizer Vaccine vs. B.1.1.7 and B.1.351 Lineages in Qatar, Reduced Hospitalizations in Vaccinated Patients ages 65 and Over, Pfizer Vaccine Effectiveness in HCW in the UK (SIREN Study), Vaccine Effectiveness Real-world Setting, Vaccine Effectiveness on Asymptomatic Infection, Vaccine Effectiveness Across Scotland, Vaccine Effectiveness Mass Vaccination Setting, Interim Vaccine Effectiveness of Pfizer mRNA Vaccine amongst HCW, FDA Guidance for Animal Studies Before Administration to Humans, Moderna Animal Studies, Pfizer Animal Studies - 2, Pfizer Animal Studies -1, J&J Animal Studies - 2, J&J Animal Studies -1, Ovarian follicular function is not altered by SARS-Cov-2 infection or BNT162b2 mRNA Covid-19 vaccination, Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons, Breakthrough Cases Pfizer Vaccine, EUA vs. FDA, Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis, Pfizer Briefing Documents, Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis, Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021, The Leading Causes of Death in the US for 2020, Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand, The Business of Making Vaccines, Costs of Influenza-related illness, 2002 Hospitalization Costs Related to Pertussis, Pricing Infectious Disease, Pediatric Care Costs, Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity, Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma, B.1.351 Antibodies Elicit Cross-Reactive Nuetralization of Older and Newer SARS-CoV-2 viral strains, Model-based evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2, Genomics and Epidemiology of the novel SARS-2 virus in Manaus, brazil, Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis, Incidence and Mortality of Thromboembolic Events: Meta-Analysis, Thrombotic Events in NYC Hospitals, Thrombotic Complications in Critically Ill ICU Patients, Incidence Of Thrombosis in Covid-19 Patients, Complete Pfizer Briefing Document with Document Adverse Events, Moderna 9-Week Median Follow-Up, Janssen/J&J Presentation, Single Dose Vaccine followed by booster at 12 Weeks, Real World Data Oxford/AstraZeneca, Oxford/AstraZeneca Efficacy vs. B.1.1.7 lineage (pre-print), mRNA Vaccine Era, mRNA Vaccines Before Covid-19, SARS-CoV-2 Antibodies detected in Human Breast milk post vaccination, Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy, Pregnancy and Covid-19: What the Data Indicates, Reassuring Data on Pregnancy and Vaccination, V-safe Pregnancy Surveillance Protocol, CDC Guidance for Personal and Social Activities, High Risk Population for Severe Outcome from a SARS-2 Infection, CDC MMWR Characteristics of Symptomatic SARS-2 in Women by Pregnancy Status, Interim CDC Recommendations for Fully Vaccinated Households, SARS-CoV-2 Transmission in Asymptomatic Carriers, Decreased Viral Load Following Vaccination, Safety and Efficacy of Janssen/J&J Viral Vector Vaccine, Delayed and Forgone Healthcare in non-elderly adults, Attachment and Close Relationships Across Life Span, Bereavement Multiplier in the United States, 2020 Healthcare Worker Burnout Survey, The Pandemic and the $16 Trillion Loss, Effectiveness of Pfizer's mRNA vaccine in Israel, Pfizer/s mRNA Vaccine Against Virus (pseudo) Variants, Moderna's mRNA Vaccine Against Virus Variants, Safety and Efficacy of Pfizer/BioNTech BNT162b2 mRNA Vaccine, Safety and Efficacy of Moderna's mRNA-1273 Vaccine, Oxford/AstraZeneca - Influence of Timing on Dose Efficacy, Oxford/AstraZeneca Vaccine Efficacy, Cost-Benefit Analysis of Vaccination vs. Infectious Disease - CDC.